captopril has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 7 (58.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, X; Wu, Y | 1 |
Wang, H; Yuan, L | 1 |
de Resende, MM; Greene, AS; Kriegel, AJ | 1 |
Börlin, HJ; Greminger, P; Hess, OM; Jenni, R; Krayenbühl, HP; Vetter, W | 1 |
Beaufort, CJ; Handlin, LR; Koenig, CA; Vacek, JL | 1 |
Böhm, M; Ettelbrück, S; Flesch, M; Knorr, A; Pinto, Y; Schiffer, F; Stasch, JP; Zolk, O | 1 |
Takeda, A; Takeda, N | 1 |
Androulakis, AE; Dernellis, J; Gialafos, JE; Kelepeshis, GA; Kyriakidis, M; Mellas, P; Triposkiadis, F | 1 |
Annoni, G; Arosio, B; Bernasconi, R; Bongrani, S; Calvillo, L; Chimenti, S; Gagliano, N; Latini, R; Limana, F; Masson, S; Razzetti, R; Salio, M; Santambrogio, D; Torri, M | 1 |
Toshima, H | 1 |
Nagano, M | 1 |
Kolarova, R; Petkov, O | 1 |
2 trial(s) available for captopril and Cardiomyopathy, Hypertrophic Obstructive
Article | Year |
---|---|
Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure.
Topics: Action Potentials; Adult; Aged; Captopril; Cardiomyopathy, Hypertrophic; Coronary Disease; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Function, Left | 1993 |
Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Hypertrophic; Coronary Circulation; Diastole; Echocardiography; Enalaprilat; Female; Heart; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left | 1998 |
10 other study(ies) available for captopril and Cardiomyopathy, Hypertrophic Obstructive
Article | Year |
---|---|
[A study of the effect of captopril on prevention and treatment of hypertrophy and its mechanism].
Topics: Animals; Captopril; Cardiomyopathy, Hypertrophic; Catechols; Disease Models, Animal; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2001 |
TCM treatment of hypertrophic cardiomyopaphy--a case report.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Metoprolol; Middle Aged | 2002 |
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Injections, Subcutaneous; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred Strains; Spironolactone; Ventricular Function, Left; Weight Loss | 2006 |
[Asymmetric septal hypertrophy in patients with arterial hypertension].
Topics: Adrenergic beta-Antagonists; Captopril; Cardiomyopathy, Hypertrophic; Diuretics; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Vasodilator Agents | 1983 |
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Blotting, Western; Calcium-Transporting ATPases; Captopril; Cardiomyopathy, Hypertrophic; Diastole; Dihydropyridines; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension; Mice; Mice, Transgenic; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sarcoplasmic Reticulum; Tetrazoles | 1997 |
Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomegaly; Cardiomyopathy, Hypertrophic; Case-Control Studies; DNA; Female; Humans; Hypertension; Male; Middle Aged | 1997 |
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload.
Topics: Adrenergic alpha-Agonists; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Captopril; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Renal; Ligation; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 2001 |
[Progress in the treatment of myocardial diseases].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Diltiazem; Echocardiography; Electrocardiography; Female; Humans; Male; Middle Aged; Verapamil | 1990 |
[ACE kininase inhibitor].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Captopril; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cricetinae; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Rats; Sarcoidosis | 1990 |
[Action of the antihypertensive effect of captopril on manifestations of hypertrophy and several parameters of myocardial metabolism].
Topics: Animals; Captopril; Cardiomyopathy, Hypertrophic; Creatine Kinase; Glucosephosphate Dehydrogenase; Hypertension, Renal; Isoenzymes; Malate Dehydrogenase; Male; Myocardium; Pyruvate Kinase; Rats; Rats, Inbred Strains | 1990 |